Supply of Plasmids and Synthetic DNA for Viral Vector Manufacture
As part of a preliminary market engagement exercise, NHS Blood & Transplant (NHSBT) are seeking to engage with suppliers of nucleic acids including plasmid DNA; synthetically produced DNA and/or enzymatically produced DNA. The intended use of the nucleic acids by NHSBT includes: a) the GMP grade production of gene therapy vectors such as lentiviral, adeno-associated viral vectors and novel gene therapy vectors, for clinical trials and commercial production where applicable; b) gene therapy vectors suitable for pre-...
Buyer
NHS Blood and Transplant
Value
£7,200,000
Published
13 Aug 2025
Closes
13 Aug 2025
Procurement details
Source
Find a Tender
Region
Bristol, City of
Procurement method
Not provided
Category
Goods
Contract starts
14 Jun 2026
Contract ends
14 Jun 2034
CPV classifications
33698000
Clinical products
Lots
Lot 1 Supply of Plasmids and Synthetic DNA for Viral Vector Manufacture
Value not provided
Delivery: UKK11 · United Kingdom
Documents
Unlock document linkPreliminary market engagement notice on Find a Tender
13 Aug 2025
Preliminary market engagement notice on Find a Tender
Market engagement notice · UK2 · Web page
Contains public sector information licensed under the Open Government Licence v3.0.